000 01468 a2200385 4500
005 20250513154243.0
264 0 _c19981204
008 199812s 0 0 eng d
022 _a0165-6147
024 7 _a10.1016/s0165-6147(98)01253-x
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aPastor-Anglada, M
245 0 0 _aTransport and mode of action of nucleoside derivatives used in chemical and antiviral therapies.
_h[electronic resource]
260 _bTrends in pharmacological sciences
_cOct 1998
300 _a424-30 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Review
650 0 4 _aAcquired Immunodeficiency Syndrome
_xdrug therapy
650 0 4 _aAnimals
650 0 4 _aAntineoplastic Agents
_xpharmacology
650 0 4 _aAntiviral Agents
_xpharmacology
650 0 4 _aBiological Availability
650 0 4 _aBiological Transport, Active
_xdrug effects
650 0 4 _aCarrier Proteins
_xdrug effects
650 0 4 _aCell Differentiation
_xdrug effects
650 0 4 _aGene Expression Regulation
_xdrug effects
650 0 4 _aHumans
650 0 4 _aNeoplasms
_xdrug therapy
650 0 4 _aNucleosides
_xpharmacology
650 0 4 _aRats
650 0 4 _aSubstrate Specificity
700 1 _aFelipe, A
700 1 _aCasado, F J
773 0 _tTrends in pharmacological sciences
_gvol. 19
_gno. 10
_gp. 424-30
856 4 0 _uhttps://doi.org/10.1016/s0165-6147(98)01253-x
_zAvailable from publisher's website
999 _c9768195
_d9768195